Clinical Trial Update: A Phase III Study of SM-13496 in Patients With Bipolar I Depression. [Phase 3]

View source ↗

Summary

Phase III study of SM-13496 in bipolar I depression completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• SM-13496

Snippet

Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2019-07-25